1036 related articles for article (PubMed ID: 10888665)
1. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.
Fornaro M; Steger CA; Bennett AM; Wu JJ; Languino LR
Mol Biol Cell; 2000 Jul; 11(7):2235-49. PubMed ID: 10888665
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways.
Kapur R; Cooper R; Zhang L; Williams DA
Blood; 2001 Apr; 97(7):1975-81. PubMed ID: 11264161
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src.
Schlaepfer DD; Hunter T
J Biol Chem; 1997 May; 272(20):13189-95. PubMed ID: 9148935
[TBL] [Abstract][Full Text] [Related]
6. Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase 2 and cytosolic phospholipase A2 but not for cytoskeletal organization.
Clark EA; Hynes RO
J Biol Chem; 1996 Jun; 271(25):14814-8. PubMed ID: 8663348
[TBL] [Abstract][Full Text] [Related]
7. Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway.
Kolkova K; Novitskaya V; Pedersen N; Berezin V; Bock E
J Neurosci; 2000 Mar; 20(6):2238-46. PubMed ID: 10704499
[TBL] [Abstract][Full Text] [Related]
8. Activated R-ras, Rac1, PI 3-kinase and PKCepsilon can each restore cell spreading inhibited by isolated integrin beta1 cytoplasmic domains.
Berrier AL; Mastrangelo AM; Downward J; Ginsberg M; LaFlamme SE
J Cell Biol; 2000 Dec; 151(7):1549-60. PubMed ID: 11134082
[TBL] [Abstract][Full Text] [Related]
9. Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal.
Sastry SK; Lakonishok M; Wu S; Truong TQ; Huttenlocher A; Turner CE; Horwitz AF
J Cell Biol; 1999 Mar; 144(6):1295-309. PubMed ID: 10087271
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc.
Miranti CK; Ohno S; Brugge JS
J Biol Chem; 1999 Apr; 274(15):10571-81. PubMed ID: 10187852
[TBL] [Abstract][Full Text] [Related]
11. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase.
Schlaepfer DD; Hanks SK; Hunter T; van der Geer P
Nature; 1994 Dec 22-29; 372(6508):786-91. PubMed ID: 7997267
[TBL] [Abstract][Full Text] [Related]
12. Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells.
Belkin AM; Zhidkova NI; Balzac F; Altruda F; Tomatis D; Maier A; Tarone G; Koteliansky VE; Burridge K
J Cell Biol; 1996 Jan; 132(1-2):211-26. PubMed ID: 8567725
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains.
Yokosaki Y; Monis H; Chen J; Sheppard D
J Biol Chem; 1996 Sep; 271(39):24144-50. PubMed ID: 8798654
[TBL] [Abstract][Full Text] [Related]
14. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A.
Pankov R; Cukierman E; Clark K; Matsumoto K; Hahn C; Poulin B; Yamada KM
J Biol Chem; 2003 May; 278(20):18671-81. PubMed ID: 12637511
[TBL] [Abstract][Full Text] [Related]
15. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected].
Chen Q; Lin TH; Der CJ; Juliano RL
J Biol Chem; 1996 Jul; 271(30):18122-7. PubMed ID: 8663436
[TBL] [Abstract][Full Text] [Related]
16. Targeting Pyk2 to beta 1-integrin-containing focal contacts rescues fibronectin-stimulated signaling and haptotactic motility defects of focal adhesion kinase-null cells.
Klingbeil CK; Hauck CR; Hsia DA; Jones KC; Reider SR; Schlaepfer DD
J Cell Biol; 2001 Jan; 152(1):97-110. PubMed ID: 11149924
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH
J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
Tai YT; Podar K; Catley L; Tseng YH; Akiyama M; Shringarpure R; Burger R; Hideshima T; Chauhan D; Mitsiades N; Richardson P; Munshi NC; Kahn CR; Mitsiades C; Anderson KC
Cancer Res; 2003 Sep; 63(18):5850-8. PubMed ID: 14522909
[TBL] [Abstract][Full Text] [Related]
19. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle.
Oktay M; Wary KK; Dans M; Birge RB; Giancotti FG
J Cell Biol; 1999 Jun; 145(7):1461-9. PubMed ID: 10385525
[TBL] [Abstract][Full Text] [Related]
20. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
